ANAEMIA FIND-CKD: intravenous iron in predialysis CKD

Publication Date

2014

Journal Title

Nat Rev Nephrol

Abstract

A new study has advanced our understanding of iron management in chronic kidney disease (CKD) by comparing oral iron to high-dose and low-dose intravenous ferric carboxymaltose (FCM) in patients with predialysis CKD. Intravenous FCM treatment to achieve a higher serum ferritin target improved patient haemoglobin levels and reduced initiation of other anaemia treatments.

Volume Number

10

Issue Number

9

Pages

488-489

Document Type

Article

EPub Date

2014/08/06

Status

Faculty

Facility

School of Medicine

Primary Department

Nephrology

PMID

25092153

DOI

10.1038/nrneph.2014.139

Full Text for Zucker SOM at Hofstra/Northwell
For the public and Northwell Health campuses

Share

COinS